Macular degeneration: open trials in Puerto Rico

5 open trials have a site in Puerto Rico. Registry data; only the trial team decides who can take part.

NCT07007065
Study to Assess the Injection Burden, Adverse Events, Change in Disease Activity, and Long-Term Preservation of Visual Acuity of Surabgene Lomparvovec in Adult Participants With Neovascular Age-Related Macular Degeneration (nAMD)
Trial Treatment · Phase 3 · AbbVie
Emanuelli Research & Development Center /ID# 264350, Arecibo
Registry updated 2026-10-29
NCT07441642
A Study to Investigate Efficacy and Safety of FWY003 Compared With Placebo in Participants With Geographic Atrophy Secondary to Age-related Macular Degeneration
Trial Treatment · Phase 2 · Novartis Pharmaceuticals
Emanuelli Research and Development Center, LLC, Arecibo
Registry updated 2026-10-13
NCT07440225
A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002)
Trial Treatment · Phase 2/3 · EyeBiotech Ltd.
Centro Oftalmologico Metropolitano, San Juan
Registry updated 2026-10-02
NCT05197270
4D-150 in Patients With Neovascular (Wet) Age-Related Macular Degeneration
Trial Treatment · Phase 1/2 · 4D Molecular Therapeutics
Emanuelli Research and Development Center, LLC, Arecibo
Registry updated 2026-08-21
NCT07230834
Intravitreal (IVT) Pozelimab for Geographic Atrophy (GA) in Adult Participants
Trial Treatment · Phase 1 · Regeneron Pharmaceuticals
Emanuelli Research and Development Center, Arecibo
Registry updated 2026-08-05

This page is not medical advice. Talk to your doctor before contacting a trial.

Study to Assess the Injection Burden, Adverse Events, Change in Disease Activity, and Long-Term Preservation of Visual Acuity of Surabgene Lomparvovec in Adult Participants With Neovascular Age-Related Macular Degeneration (nAMD)